AbCellera Biologics Stock

Antibody therapeutics

About AbCellera Biologics Stock

AbCellera Biologics offers development of antibody therapeutics to improve patient outcomes.

Funding History

September 2013	$0
August 2014	$0
January 2017	$0
April 2017	$818K
September 2018	$10.0M
March 2019	$4.8M

Management

Co-Founder

Kevin Heyries

Co-Founder & Director

Véronique Lecault

Other Companies

Learn More

Arvinas

Arvinas is a pharmaceutical company focused on protein degradation approaches to develop novel drugs to treat cancer and other diseases.

Multinational pharmaceutical and life sciences company

Seven Bridges is the leading biomedical data science company.

Synaptive is a medical device and technology company pursuing connections to transform the process of care in and beyond the operating room.

8Age (years)

$6.9MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from AbCellera Biologics or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 100K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.